SEC Form 8-K filed by CONMED Corporation
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
| (Address of principal executive offices) | (Zip code) |
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (See General Instruction A.2 below):
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Rule 12(b) of the Act
| Title of each class |
Trading Symbol |
Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On September 16, 2024, Eric B. Staves, Vice President, Corporate Controller, informed CONMED Corporation (the “Company”) that, effective September 27, 2024, he plans to leave the Company to pursue an executive opportunity. Kimberly A. Lockwood, Director of Financial Reporting & Controls, will serve as Interim Corporate Controller, effective September 30, 2024. Todd W. Garner, Executive Vice President of Finance and Chief Financial Officer, will assume the role of Principal Accounting Officer. Terence M. Berge, retired Vice President, Corporate Controller, continues to serve as Special Advisor to the Company and remains available to support the Company and Ms. Lockwood.
Ms. Lockwood joined the Company in 2005 as the Director, Financial Reporting & Controls. Prior to joining the Company, Ms. Lockwood was employed by PricewaterhouseCoopers LLP’s Assurance and Business Advisory Services group. Ms. Lockwood is a certified public accountant and holds a Bachelor of Science degree in Accounting from Le Moyne College.
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: September 20, 2024 | CONMED CORPORATION | |||||
| (Registrant) | ||||||
| By: | /s/ Todd W. Garner | |||||
| Name: | Todd W. Garner | |||||
| Title: | Executive Vice President-Chief Financial Officer | |||||